Tennis Pro Caroline Wozniacki’s Advantage Hers Campaign Supports Women with Inflammatory Conditions

Caroline Wozniacki has led an interesting life. Born in Denmark, she was immediately thrust into athleticism. Her father was a former football player (that's soccer for you Americans) and her…

Continue Reading Tennis Pro Caroline Wozniacki’s Advantage Hers Campaign Supports Women with Inflammatory Conditions
BioMarin Holds Clinical Study to Determine Antibodies that Might Impact Gene Therapy
GCMpublicitat / Pixabay

BioMarin Holds Clinical Study to Determine Antibodies that Might Impact Gene Therapy

Last month, biotechnology company BioMarin sought approval for an investigational gene therapy (valoctocogene roxaparvovec) for patients with hemophilia A. However, their approval was denied. Instead, the company was told that…

Continue Reading BioMarin Holds Clinical Study to Determine Antibodies that Might Impact Gene Therapy
Cornell and reVision Therapeutics Will Work Together to Develop Stargardt Disease Treatment
source: pixabay.com

Cornell and reVision Therapeutics Will Work Together to Develop Stargardt Disease Treatment

Cornell University and reVision Therapeutics have come together through a licensing agreement to develop a treatment for Stargardt disease, according to BioSpace. They will be working on and commercializing Cornell's…

Continue Reading Cornell and reVision Therapeutics Will Work Together to Develop Stargardt Disease Treatment

Researchers at Nagoya University are One Step Closer to Unraveling the Tau Mystery in Neurodegenerative Diseases

According to a recent article in MedicalXpress, researchers in Japan led by Dr. Shinsuke Ishigaki and his team at Nagoya University, have identified new molecular details about tau’s activity. Alzheimer’s,…

Continue Reading Researchers at Nagoya University are One Step Closer to Unraveling the Tau Mystery in Neurodegenerative Diseases
COVID-19 and Heart Damage: What You Need to Know
source: pixabay.com

COVID-19 and Heart Damage: What You Need to Know

According to a story from Buzzfeed News, the coronavirus/COVID-19 pandemic continues to present new surprises and challenges to the medicine and science communities. In a recent interview, Wayne Sebastianelli, who…

Continue Reading COVID-19 and Heart Damage: What You Need to Know
Pulmonary Arterial Hypertension Drug Adempas Achieves Primary Endpoint in Recent Trial
source: pixabay.com

Pulmonary Arterial Hypertension Drug Adempas Achieves Primary Endpoint in Recent Trial

According to a story from Pharmaceutical Business Review, the pharmaceutical company Bayer has recently announced encouraging findings from its phase 4 clinical study. This trial was testing the drug riociguat…

Continue Reading Pulmonary Arterial Hypertension Drug Adempas Achieves Primary Endpoint in Recent Trial